CRISPR-SCReT (CRISPR-Stop Codon Read Through) method to control Cas9 expression for gene editing
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR-SCReT (CRISPR-Stop Codon Read Through) method to control Cas9 expression for gene editing
Authors
Keywords
-
Journal
GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-01
DOI
10.1038/s41434-021-00297-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolving AAV-delivered therapeutics towards ultimate cures
- (2021) Xiangjun He et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The promise and challenge of therapeutic genome editing
- (2020) Jennifer A. Doudna NATURE
- Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia
- (2020) Monica Borgatti et al. Journal of Clinical Medicine
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency
- (2020) Jonathan Frew et al. Molecular Neurodegeneration
- AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
- (2020) Ang Li et al. MOLECULAR THERAPY
- Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies
- (2020) Nicole D. Marino et al. NATURE METHODS
- Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
- (2020) Peter Gee et al. Nature Communications
- Chemical modifications of G418 (geneticin): Synthesis of novel readthrough aminoglycosides results in an improved in vitro safety window but no improvements in vivo
- (2020) Ramil Y. Baiazitov et al. CARBOHYDRATE RESEARCH
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
- (2019) Danny Wilbie et al. ACCOUNTS OF CHEMICAL RESEARCH
- A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9
- (2019) Basudeb Maji et al. CELL
- Rationally Designed Small Nucleic Acid-Based Inhibitors of CRISPR-Cas9
- (2019) Christopher L. Barkau et al. Nucleic Acid Therapeutics
- The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418
- (2019) Michael W. Ferguson et al. PLoS One
- Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein
- (2019) Ran Chen et al. Small
- Protein Inhibitors of CRISPR-Cas9
- (2018) Joseph Bondy-Denomy ACS Chemical Biology
- A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies
- (2018) Daniel R. McHugh et al. PLoS One
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
- (2018) Benjamin L. Duchêne et al. MOLECULAR THERAPY
- The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
- (2018) Westley J. Friesen et al. PLoS One
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Safe CRISPR: Challenges and Possible Solutions
- (2018) Michael Pineda et al. TRENDS IN BIOTECHNOLOGY
- A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
- (2018) Ang Li et al. Molecular Therapy-Methods & Clinical Development
- Mechanism and evidence of nonsense suppression therapy for genetic eye disorders
- (2017) Rose Richardson et al. EXPERIMENTAL EYE RESEARCH
- Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases
- (2017) Hana Benhabiles et al. PLoS One
- Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
- (2017) Serif Senturk et al. Nature Communications
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
- (2017) Gianluca Petris et al. Nature Communications
- Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
- (2016) Maximilian W. Popp et al. CELL
- Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia
- (2016) D L Ouellet et al. GENE THERAPY
- Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
- (2016) Alireza Baradaran-Heravi et al. NUCLEIC ACIDS RESEARCH
- Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
- (2016) Jean-Paul Iyombe-Engembe et al. Molecular Therapy-Nucleic Acids
- CRISPR, un système qui permet de corriger ou de modifier l’expression de gènes responsables de maladies héréditaires
- (2015) Jacques P. Tremblay M S-MEDECINE SCIENCES
- Therapeutics Based on Stop Codon Readthrough
- (2014) Kim M. Keeling et al. Annual Review of Genomics and Human Genetics
- Structural basis for the inhibition of the eukaryotic ribosome
- (2014) Nicolas Garreau de Loubresse et al. NATURE
- Suppression of premature termination codons as a therapeutic approach
- (2012) Kim M. Keeling et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Thérapie spécifique d’allèle
- (2012) Célia Floquet et al. M S-MEDECINE SCIENCES
- Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy
- (2010) Vinod Malik et al. Therapeutic Advances in Neurological Disorders
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
- (2009) Linda Madisen et al. NATURE NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search